The CDC recently made headlines by reducing the isolation time for COVID-19 in the general public from 5 days to just 24 hours. This decision was met with criticism from organizations like National Nurses United (NNU), who expressed concerns about the potential risks to public health caused by this change. While the updated guidelines do
Health
Neurological disorders are a significant global health issue, affecting a staggering 3.4 billion people worldwide, according to a systematic analysis for the Global Burden of Disease Study. This analysis revealed that neurologic conditions impacted 43.1% of the world’s population, making it the leading cause of ill health and disability globally in 2021. In 2021, 37
In recent years, the American West has witnessed a concerning trend in the surge of hospital admissions for cardiomyopathy associated with methamphetamine use. According to a study analyzing 13 years of data from the National Inpatient Sample (NIS), the admissions for methamphetamine-related cardiomyopathy soared by 231% between 2008 and 2020. This stark increase far outpaced
Space travel has long been a subject of fascination and exploration. However, recent studies have shed light on a surprising side effect of long-haul space flights – headaches. A prospective study conducted on 24 healthy astronauts revealed that a staggering 91.7% of them experienced one or more headaches during a total of 3,596 space days.
A recent observational study conducted in Sweden has shed light on the relationship between medication for attention-deficit/hyperactivity disorder (ADHD) and mortality rates among patients diagnosed with the condition. The study, led by Zheng Chang, PhD, from the Karolinska Institute in Stockholm, revealed some interesting findings regarding the effects of ADHD medication on the risk of
Grace Armant, an 84-year-old ALS patient, has been struggling to get coverage for a machine she needs to breathe. UnitedHealthcare has been rejecting requests from her doctors, causing frustration and difficulties for Armant and her family. This situation is just one of many cases where insurance companies are making it increasingly challenging for patients to
Richard Lowenthal, president and CEO of ARS Pharmaceuticals, conducted tests on intranasal epinephrine spray ARS-1 (also known as neffy) under extreme temperatures, prompted by parents who expressed concerns about leaving the EpiPen in the car. This raises questions about the practicality and effectiveness of current emergency medication solutions. Dr. Landon Myer from the University of
UnitedHealth Group’s immense financial success in 2023, with nearly $400 billion in revenue and $22.4 billion in profits, raises concerns about its impact on the healthcare industry. Through vertical integration, UHG has created a value-chain monopoly, controlling everything from health insurance to medical services to pharmaceuticals. This consolidation raises questions about the implications for clinicians,
Research has shown that individuals with persistent amblyopia, commonly known as “lazy eye,” from childhood may have an increased risk of developing cardiometabolic disorders in adulthood. A recent observational cohort study conducted within the U.K. Biobank revealed that individuals over the age of 40 living with amblyopia were more likely to suffer from conditions such
Tuberculosis (TB) remains a significant global health concern, affecting both individuals with HIV and those without. The current standard treatment for TB often involves the use of ethionamide, a drug known for its efficacy against the disease but also for its high rates of intolerability due to severe gastrointestinal side effects. In light of this